| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,873 |
5,866 |
$224K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,647 |
1,329 |
$45K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,120 |
909 |
$40K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,506 |
1,204 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,610 |
1,251 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,666 |
1,342 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,018 |
769 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
94 |
76 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
43 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
2,357 |
1,837 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
120 |
100 |
$922.42 |
| 90686 |
|
96 |
81 |
$892.88 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15 |
14 |
$588.32 |
| 96160 |
|
28 |
25 |
$580.58 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15 |
13 |
$454.79 |
| 81003 |
|
279 |
223 |
$321.26 |
| 90688 |
|
18 |
17 |
$210.69 |
| 87807 |
|
19 |
15 |
$164.99 |
| 90661 |
|
17 |
16 |
$116.13 |
| 96127 |
|
28 |
25 |
$109.33 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
29 |
25 |
$11.43 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$7.38 |